A股異動 | 易華錄一度升9% 近日走出反轉行情 併入中國電科迎新進展
易華錄(300212.SZ)盤中一度拉昇升至9%,最高報38.1元創2個月新高,近7日自低位累計升幅達40%走出反轉行情,總市值248億元。消息面上,北京市市場監督管理局發佈“中國電子科技集團有限公司收購中國華錄集團有限公司股權案”,公示期為2023年9月1日至2023年9月10日。作為今年以來第一例央企重組案例,中國電科和華錄集團的重組事項自公佈以來便引起了市場的關注。市場人士認為,華錄集團和中國電科重組將形成資源互補,進一步整合國家隊力量。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.